Shareholder Vote

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549  _______________ FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934  _______________ Date of Report:  May 6, 2022 (Date of earliest event reported)  _______________ TENET HEALTHCARE CORP ORATION (Exact name of Registrant as specified in its charter)   Nevada   1-7293   95-2557091 (State of Incorporation)   (Commission File Number)   (IRS Employer Identification Number) 14201 Dallas Parkway Dallas , TX   75254 (Address of principal executive offices, including zip code) ( 469 ) 893-2200 (Registrant’s telephone number, including area code)   Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common stock, $0.05 par value THC NYSE 6.875% Senior Notes due 2031 THC31 NYSE Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging Growth Company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards pursuant to Section 13(a) of the Exchange Act. ☐ Item 5.07. Submission of Matters to a Vote of Security Holders. The 2022 Annual Meeting of Shareholders of Tenet Healthcare Corporation (the “Company”) was held on May 6, 2022. Below are the final voting results from the meeting. 1.    The Company’s shareholders elected the following nominees to serve on the Company’s Board of Directors, each to serve until the next annual meeting of shareholders or until his or her successor is duly elected or qualified, whichever is later, or until the director’s earlier resignation or removal: FOR AGAINST ABSTAIN BROKER NON-VOTES Ronald A. Rittenmeyer 86,706,445 1,288,932 47,943 6,803,958 J. Robert Kerrey 85,492,681 2,503,766 46,873 6,803,958 James L. Bierman 86,145,447 1,850,863 47,010 6,803,958 Richard W. Fisher 87,315,477 679,897 47,946 6,803,958 Meghan M. FitzGerald 86,411,402 1,590,382 41,536 6,803,958 Cecil D. Haney 86,575,789 1,421,227 46,304 6,803,958 Christopher S. Lynch 87,317,502 678,600 47,218 6,803,958 Richard J. Mark 87,318,842 677,309 47,169 6,803,958 Tammy Romo 87,293,370 708,767 41,183 6,803,958 Saumya Sutaria 87,925,812 79,060 38,448 6,803,958 Nadja Y. West 86,580,713 1,417,636 44,971 6,803,958 2.    The Company’s shareholders approved, on an advisory basis, the Company’s executive compensation: FOR AGAINST ABSTAIN BROKER NON-VOTES 85,140,056 2,843,356 59,908 6,803,958 3.    The Company’s shareholders approved the First Amendment to the Tenet Healthcare 2019 Stock Incentive Plan. FOR AGAINST ABSTAIN BROKER NON-VOTES 85,632,550 2,347,730 63,040 6,803,958 4     The Company’s shareholders approved the ratification of the selection of Deloitte & Touche LLP as the Company’s independent registered public accountants for the year ending December 31, 2022: FOR AGAINST ABSTAIN BROKER NON-VOTES 93,860,868 910,170 76,240 -0- SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. TENET HEALTHCARE CORPORATION Date: May 9, 2022 By: /s/ T HOMAS A RNST Name: Thomas Arnst Title: Executive Vice President, Chief Administrative Officer, General Counsel and Corporate Secretary